Related Experiment Video
Updated: Dec 25, 2025
07:22
Arthroscopic Management of Massive Irreparable Rotator Cuff Tears: Whole Rotator Cable Reconstruction Using Proximal Biceps Tendon Autograft
Published on: June 6, 2025
456
Clinical Outcomes Following Biologically Enhanced Patch Augmentation Repair as a Salvage Procedure for Revision
Lukas N Muench1, Cameron Kia2, Aulon Jerliu2
1Department of Orthopaedic Surgery, UConn Health Center, Farmington, Connecticut, U.S.A.; Department of Orthopaedic Sports Medicine, Technical University of Munich, Germany.
Summary
Biologically enhanced patch augmentation for revision massive rotator cuff tears showed limited success. Only 41% of patients achieved substantial clinical benefit, with higher cell counts in successful cases.
Area of Science:
- Orthopedic Surgery
- Regenerative Medicine
- Biomaterials
Background:
- Revision rotator cuff tears present significant surgical challenges.
- Biologically enhanced techniques aim to improve healing and outcomes in complex repairs.
Purpose of the Study:
- To evaluate clinical outcomes of revision massive rotator cuff tears treated with biologically enhanced patch augmentation.
- To assess the efficacy of platelet-rich plasma and concentrated bone marrow aspirate in augmenting rotator cuff repair.
Main Methods:
- Retrospective case series of 22 patients with revision massive rotator cuff tears.
- Arthroscopic and mini-open repair using augmented patches with platelet-rich plasma and concentrated bone marrow aspirate (cBMA).
- Clinical outcomes assessed using ASES, Simple Shoulder Test, and SANE scores; clinical success defined by substantial clinical benefit (SCB).
- In vitro analysis of cell counts and connective tissue progenitor cells in patch samples.
Main Results:
- Significant improvement in Simple Shoulder Test scores (P = .01).
- Non-significant improvements in pain and ASES scores (P = .11 and P = .10, respectively).
- 41% of patients achieved SCB, and 32% met patient-acceptable symptomatic state (PASS) criteria.
- Higher cell counts in scaffolds at 21 days correlated with clinical success (P = .02).
Conclusions:
- Biologically enhanced patch augmentation for revision massive rotator cuff tears yielded suboptimal clinical success rates.
- While some functional improvements were noted, a significant portion of patients did not reach clinically meaningful benefit thresholds.
- In vitro cell proliferation in augmented patches may correlate with surgical outcomes.
